Erich Pawelka
Favoriten, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Cefepime/enmetazobactam for invasive infections caused by extended-spectrum beta-lactamase-producing Enterobacterales: a real-world case series.
Journal: Infection
Published: June 08, 2026
Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients : A propensity score matched analysis.
Journal: Wiener klinische Wochenschrift
Published: July 04, 2022
Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers.
Journal: Journal of infection and public health
Published: June 12, 2022
Comparison of clinical characteristics among patients infected with alpha vs. delta SARS-CoV-2 variants.
Journal: Wiener klinische Wochenschrift
Published: April 11, 2022
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT).
Journal: Frontiers in pharmacology
Published: February 07, 2022
COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age-Propensity Score-Matched Analysis of Austrian National Public Health Institute Data.
Journal: Viruses
Published: November 05, 2021
Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications.
Journal: Frontiers in cardiovascular medicine
Published: October 26, 2021
Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype.
Journal: Frontiers in cardiovascular medicine
Published: October 15, 2021
A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation.
Journal: Frontiers in cellular and infection microbiology
Published: October 14, 2021
Last Updated: 09/26/2026